Keshav Raj Paudel

Dr. Keshav Raj Paudel

University of Technology Sydney, Sydney, New South Wales, Australia
+1
orcid

Biography

Dr. Keshav Raj Paudel is a senior post-doctoral researcher at the Centenary UTS Center for Inflammation, Faculty of Science, the University of Technology Sydney, Sydney, Australia. He obtained his M.Sc. and Ph.D. from Mokpo National University, Republic of Korea, in 2014 and 2017, respectively and his first post-doc position at UTH, Texas, USA. After joining UTS, Sydney, for a second postdoc position through an IASLC fellowship, his research has focused on the field of chronic respiratory disease, exploring the disease progression and pharmacological activity of drug candidates on various lung diseases (asthma, airway remodeling, COPD, and lung cancer) in experimental models (in vitro, in vivo, and ex vivo) using molecular, immunological, and biochemical assays. He is interested in exploring the cell signaling pathways of various inflammation-related disorders induced by environmental pollutants such as bushfire smoke/particulate matter, air pollutants (urban particulate matter, traffic pollutants), and microplastics. He is currently involved in a research project aimed to explore the impact of bushfire smoke on respiratory health funded by an Australian government grant (MRFF grant), HEAL network grant, Triple I seed grant, and TSANZ grant-in-aid. He is also a node leader of the bushfire study at the Centre for Inflammation, Centenary Institute and UTS, led by Prof. Philip M. Hansbro.

Affiliations

University of Technology Sydney

Sydney, New South Wales, Australia

Centenary Institute of Cancer Medicine and Cell Biology

Sydney, New South Wales, Australia

Honors and Awards

honor

IASLC/PCF fellowship for lung cancer study

International Association for the Study of Lung Cancer (IASLC) Foundation, Prevent Cancer Foundation

https://www.preventcancer.org/programs/our-global-reach/global-research-grants/ Institution: The University of Technology, Sydney, Australia Study: The identification of a small subset of microRNAs found in body fluids. This project aims to advance the study of microRNAs, which have shown great potential as a new class of biomarkers in cancer and could allow for non-invasive early detection of locally confined lung cancers. Time: 2 years (2019-2020) Fund: 250,000 USD

Experience

No experience has been shared yet.